Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15010063
Abstract: Passive administration of neutralizing antibodies (Abs) is an attractive strategy for the control of gastrointestinal infections. However, an unanswered practical concern is the need to assure the stability of sufficient amounts of orally administered neutralizing… read more here.
Keywords: norovirus infection; lactobacilli vector; vhh 1e4;